tiprankstipranks
Piper Sandler Keeps Their Sell Rating on Aemetis (AMTX)
Blurbs

Piper Sandler Keeps Their Sell Rating on Aemetis (AMTX)

In a report released today, Ryan Todd from Piper Sandler maintained a Sell rating on Aemetis (AMTXResearch Report), with a price target of $3.00. The company’s shares closed yesterday at $3.79.

According to TipRanks, Todd is a 5-star analyst with an average return of 8.3% and a 58.85% success rate. Todd covers the Energy sector, focusing on stocks such as PBF Energy, Par Pacific Holdings, and HF Sinclair Corporation.

Aemetis has an analyst consensus of Moderate Buy, with a price target consensus of $15.13.

The company has a one-year high of $8.99 and a one-year low of $1.16. Currently, Aemetis has an average volume of 1.27M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Aemetis (AMTX) Company Description:

Aemetis, Inc. operates as a renewable fuels and biochemicals company. The firm focuses on the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into biorefineries. It operates through the North America and India segments. The North America segment comprises of the Keyes Plant in California, the cellulosic ethanol facility in Riverbank, the cluster of biogas digesters on dairies near Keyes, the Goodland Plant, and the research and development facility in Minnesota. The India segment includes the Kakinada plant, administrative offices in Hyderabad, and holding companies in Nevada and Mauritius. Its products include glycerin, ethanol, food and feed, biodiesel, and edible oils. The company was founded by Eric Armstrong McAfee in 2005 and is headquartered in Cupertino, CA.

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles